Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Opko Health, Inc.. Director active across 1 company, notably GeneDx Holdings Corp.. Aggregated, 12 filings have been published. Breakdown: 1 buy · 10 sells. Total volume traded: €18.3m. Activity tracked since 26 January 2023. The latest transaction was disclosed on 15 August 2024 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Opko Health, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14,285,714 shares@ US$0.3525.0% of flowClass A Common StockSEC:0001209191-23-005821:0
Canonical exit: 26 Apr 2023 (T+90)
12 of 12 declarations
About Opko Health, Inc.
OPKO HEALTH, INC. is a declarant linked to GeneDx Holdings Corp. on XNAS. The 12 filings recorded cover the period from 2023-01-31 to 2024-08-19, and, in the recent filing sample held, the amounts shown are EUR 4577900 of buys and EUR 13730261 of sells, with the dominant transaction nature indicated as Sale.